Back
Corporate News
Gland Pharma appoints Deepak Sapra as CEO, effective November 2026, pending acceptance
14-Aug-2026, 09:31
Gland Pharma Limited announced the appointment of Mr. Deepak Sapra as the new Chief Executive Officer (CEO), subject to his acceptance of the offer, with an effective date of November 16, 2026. Mr. Sapra, who currently serves as Chief Executive Officer – API and Services at Dr. Reddy’s Laboratories Limited and a Board Member of Aurigene Pharma Services, brings 27 years of executive experience, including over 23 years in the pharmaceutical industry.
Gland Pharma Limited announced the appointment of Mr. Deepak Sapra as the new Chief Executive Officer (CEO), subject to his acceptance of the offer, with an effective date of November 16, 2026. Mr. Sapra, who currently serves as Chief Executive Officer – API and Services at Dr. Reddy’s Laboratories Limited and a Board Member of Aurigene Pharma Services, brings 27 years of executive experience, including over 23 years in the pharmaceutical industry.